Correlation Between Westlake Chemical and Crispr Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Westlake Chemical and Crispr Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Westlake Chemical and Crispr Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Westlake Chemical and Crispr Therapeutics AG, you can compare the effects of market volatilities on Westlake Chemical and Crispr Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Westlake Chemical with a short position of Crispr Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Westlake Chemical and Crispr Therapeutics.

Diversification Opportunities for Westlake Chemical and Crispr Therapeutics

  Correlation Coefficient

Very good diversification

The 3 months correlation between Westlake and Crispr is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Westlake Chemical and Crispr Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crispr Therapeutics and Westlake Chemical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Westlake Chemical are associated (or correlated) with Crispr Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crispr Therapeutics has no effect on the direction of Westlake Chemical i.e., Westlake Chemical and Crispr Therapeutics go up and down completely randomly.

Pair Corralation between Westlake Chemical and Crispr Therapeutics

Considering the 90-day investment horizon Westlake Chemical is expected to generate 0.57 times more return on investment than Crispr Therapeutics. However, Westlake Chemical is 1.77 times less risky than Crispr Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Crispr Therapeutics AG is currently generating about -0.03 per unit of risk. If you would invest  7,934  in Westlake Chemical on September 4, 2022 and sell it today you would earn a total of  2,930  from holding Westlake Chemical or generate 36.93% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
ValuesDaily Returns

Westlake Chemical  vs.  Crispr Therapeutics AG

 Performance (%) 
Westlake Chemical 
Westlake Performance
6 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Westlake Chemical are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady essential indicators, Westlake Chemical demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Westlake Price Channel

Crispr Therapeutics 
Crispr Performance
0 of 100
Over the last 90 days Crispr Therapeutics AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm insiders.

Crispr Price Channel

Westlake Chemical and Crispr Therapeutics Volatility Contrast

   Predicted Return Density   

Pair Trading with Westlake Chemical and Crispr Therapeutics

The main advantage of trading using opposite Westlake Chemical and Crispr Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Westlake Chemical position performs unexpectedly, Crispr Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crispr Therapeutics will offset losses from the drop in Crispr Therapeutics' long position.
Westlake Chemical vs. Anheuser-Busch InBev SANV
Westlake Chemical vs. Etsy Inc
Westlake Chemical vs. Anheuser Busch Inbev
Westlake Chemical vs. Linde PLC
The idea behind Westlake Chemical and Crispr Therapeutics AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Crispr Therapeutics vs. Acer Therapeutics
Crispr Therapeutics vs. Aurora Cannabis
Crispr Therapeutics vs. Agilent Technologies
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Technical Analysis
Check basic technical indicators and analysis based on most latest market data